Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP-PEPC in Knee Osteoarthritis
NCT07491367Phase 4Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 4 trial of autologous platelet-rich plasma in knee osteoarthritis (OA), sponsored by University of California, San Francisco. Started Sep 2026; status: recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07491367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07491367.